Recent Searches

    Study Suggests New York Will Miss Cannabis Tax Revenue Targets

    By

    The Coalition for Access to Regulated & Safe Cannabis (CARSC) has released a report detailing the severe degree to which the State’s adult-use cannabis program is failing to meet tax revenue targets.

    The organisation, which represents licensed registered medical cannabis operators and equity applicants excluded from New York’s nascent adult-use market, has predicted that New York would generate $56 million in state cannabis tax revenues in the first year of legal adult-use sales.

    The majority of that money — $40 million — will come from licensing fees paid by growers and sellers.

    This means that the state is barely on track to overtake Montana in first year adult-use cannabis tax revenue, while Illinois generated five times more tax revenue in year one than New York is projected to attain.

    Rev. Kirsten Foy stated: “Even if New York reached its $56 million projection, which is highly unlikely at the current pace, the state will have generated less tax revenue than Massachusetts, Oregon and Michigan did in their first year of adult-use cannabis sales. That is completely unacceptable.

    READ MORE: U.S. Cannabis Industry in Crisis Shows Report

    “How is it that Montana with less than half the population of Queens can generate nearly $42 million in new tax revenue in their first year of adult-use cannabis sales but New York can’t get its act together to break $56 million?

    “The answer is simple: the Office of Cannabis Management’s (OCM) anemic pace of licensing has allowed the illicit market to thrive while vetted social equity applicants and registered organizations languish in a bureaucratic morass with little hope of competing. As a result, Social Equity applicants have been harmed most because they are ostensibly the beneficiaries of the tax revenue, which is non-existent, while simultaneously being the least equipped to to compete with the illicit market.

    “The current state of the cannabis market in New York is an unmitigated disaster. Despite its enormous potential, regulators have neglected their responsibilities and their failure to act puts consumers at risk, restricts equity participation and the MRTA’s intended beneficiaries – disproportionately impacted communities – are missing out on millions of dollars of critical tax revenue while putting consumers at risk.”

    Stephanie Price

    Stephanie is a journalist for Business of Cannabis, writing about science, research, policy and industry developments in cannabis, CBD and psychedelics. In 2013 Stephanie gained her BA in English and Media, focusing on journalism and propaganda, where her magazine ‘Game Theory’ focused on developments and disruptors over the coming decade including cannabis, psychedelics, blockchain/crypto and free speech. In 2015 Stephanie received her National Council for the Training of Journalists (NCTJ) diploma whilst working as a reporter in North Wales. Stephanie has a specialism in Medical Cannabis: The Health Effects of THC and CBD through the University of Colorado, and a certificate from the Medical Cannabis Clinicians Society on “Medical Cannabis Explained”.